(VIANEWS) – The Market ended the session with NYXOAH (NYXH.BR) rising 15.93% to €5.75 on Monday, following the last session’s downward trend. BEL 20 fell 0.08% to €3,881.94, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.
NYXOAH’s last close was €4.96, 73.89% under its 52-week high of €19.00.
About NYXOAH
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Earnings Per Share
As for profitability, NYXOAH has a trailing twelve months EPS of €-0.68.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.17%.
More news about NYXOAH (NYXH.BR).
